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a  b  s  t  r  a  c  t
The  tick  Rhipicephalus  (Boophilus)  microplus  is  a blood-sucking  ectoparasite  of  cattle  that  severely  impairs
livestock  production.  Studies  on  tick  immunological  control  address  mostly  single-antigen  vaccines.
However,  from  the  commercial  standpoint,  so  far  no  single-antigen  vaccine  has  afforded  appropriate
protection  against  all R.  microplus  populations.  In this  context,  multi-antigen  cocktails  have  emerged
as  a way  to  enhance  vaccine  efﬁcacy.  In this  work,  a  multi-antigenic  vaccine  against  R. microplus  was
analyzed  under  ﬁeld  conditions  in naturally  infested  cattle.  The  vaccine  was  composed  by three  tick
recombinant  proteins  from  two  tick  species  that  in  previous  single-vaccination  reports  provided  partial
protection  of  conﬁned  cattle  against  R.  microplus  infestations:  vitellin-degrading  cysteine  endopepti-
dase  (VTDCE)  and  boophilus  yolk  pro-cathepsin  (BYC)  from  R. microplus,  and  glutathione  S-transferase
from  Haemaphysalis  longicornis  (GST-Hl).  Increased  antibody  levels  against  three  proteins  were  recordeditellin-degrading cysteine endopeptidase
oophilus yolk pro-cathepsin
after  immunizations,  with  a  distinct  humoral  immune  response  dynamics  for  each  protein.  Compared  to
the  control  group,  a statistically  signiﬁcant  lower  number  of  semi-engorged  female  ticks  were  observed
in  vaccinated  cattle  after  two  inoculations.  This  reduction  persisted  for 3  months,  ranging  from  35.3 to
61.6%.  Furthermore,  cattle  body  weight  gain  was  signiﬁcantly  higher  in  vaccinated  animals  when  com-
pared  to control  cattle.  Compared  to  the  single-antigen  vaccines  composed  by  VTDCE,  BYC  or GST-Hl,  this
ordedthree-antigen  vaccine  aff∗ Corresponding author at: Centro de Biotecnologia, Universidade Federal do Rio
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1. Introduction
The tick Rhipicephalus (Boophilus) microplus has a signiﬁcant
economic impact on cattle breeding industry worldwide, estimated
at billions of dollars annually [1,2]. This parasite causes a variety of
deleterious effects in cattle, mainly as result of bodyweight reduc-
tion, blood loss and the transmission of disease-causing agents
[1,2]. The intensive use of acaricides in order to control tick infes-
tation raises concerns as to the potential presence of pesticide
residues in milk, meat, and the environment [3]. For these reasons,
Open access under the Elsevier OA license.a tick vaccine, as an alternative control method, is a major economic
issue [4,5].
It  has been repeatedly demonstrated that the stimulation of
bovine immune system by tick proteins vaccination induces a
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rotective immune response against R. microplus [6]. In 1986, a
rotective protein from R. microplus named Bm86 was discov-
red, when this antigen became the ﬁrst tick antigen to compose
 commercial vaccine against an ectoparasite [7]. Although vac-
ine formulations based on Bm86 in most cases elicit protective
mmune responses against R. microplus, they vary considerably in
erms of protection level depending, among other things, on the
enetic variability of tick and bovine populations [8–13]. There-
ore, the discovery of new tick antigens focusing on those displaying
inimal genetic variability among R. microplus populations could
mprove vaccination efﬁcacy and reduce variation in the protec-
ion level afforded by the Bm86-based vaccines. However, except
or a few studies [14], data regarding cross-reactivity between tick
roteins are scarce, although some tick antigens have been shown
o induce cross-protective immunity against some tick species
14,15]. Another strategy to enhance anti-tick vaccine efﬁcacy is
o combine two or more antigens [16]. The initial proof of con-
ept supporting this approach came from vaccination experiments,
n which mixtures of antigens were more efﬁcacious than single
omponents, including Bm86 [4]. Some experimental studies used
his approach against tick infestations [16–23]; however, in most
ases, this strategy resulted in a statistical signiﬁcant but slightly
mprovement in protection level.
Although tick infestation experiments using bovines in con-
ned indoors can indicate vaccine efﬁcacy, ﬁeld trials are necessary
o evaluate vaccine performance under real husbandry conditions
24]. However, most of the protocols used in experiments to eval-
ate bovine vaccination against ticks employ conﬁned bovines,
 more practical and cost-saving approach, compared to ﬁeld
xperiments which demand laborious handling of cattle and the
vailability of a large area [16,25]. Our research group has been
tudying several R. microplus molecules in order to ﬁnd antigens
hat could be used in an anti-tick vaccine. In previous stud-
es, immunizations of cattle with native or recombinant forms
f an aspartic protease named BoophilusYolk pro-cathepsin (BYC)
nduced overall protections (measured by the reproductive poten-
ial, including reduction in number and weight of engorging ticks
nd in egg weight and hatchability) around 30% [26,27]. Also,
mmunization with a R. microplus cysteine endopeptidase (VTDCE),
nvolved in vitellin digestion [28,29], elicited an immunoprotection
f 21% in vaccinated cattle [30]. More recently, an overall protective
fﬁcacy of 57% against R. microplus was achieved using a recombi-
ant Haemaphysalis longicornis GST (rGST-Hl) [31]. In this work, we
valuated a multi-antigenic vaccine composed by BYC, VTDCE and
ST-Hl recombinant proteins against R. microplus infestation in cat-
le. Vaccine efﬁciency was evaluated under ﬁeld conditions, based
n semi-engorged female tick numbers and weight gain differences
etween vaccinated and control cattle groups.
. Materials and methods
.1.  Expression of the recombinant proteins
rGST-Hl, rBYC, and rVTDCE were expressed and puriﬁed as
reviously described [32–34]. Brieﬂy, rBYC and rGST-Hl were
xpressed in Escherichia coli strain AD494 (DE3) pLysS. Recom-
inant VTDCE was expressed in E. coli strain BL21 (DE3) Star.
he insoluble forms of rBYC and rVTDCE were solubilized with
 M guanidine hydrochloride (GuHCl) and puriﬁed using a nickel-
helating Sepharose column (GE Healthcare, Uppsala, Sweden). The
oluble form of recombinant GST-Hl was puriﬁed through afﬁnity
hromatography using GSTrap FF column (GE Healthcare, Uppsala,
weden). Protein concentrations were determined by the Bradford
ethod [35] and sodium dodecyl sulfate-polyacrylamide gel elec-
rophoresis (SDS-PAGE) using bovine serum albumin as standard. (2012) 6912– 6917 6913
2.2. Animals
From September 2009 to January 2010 (spring to summer),
a total of 38 Aberdeen Angus and Devon cattle heads (15 ± 1-
month-old) the beginning of the trial were maintained under ﬁeld
conditions in a experimental farm (Estac¸ ão FEPAGRO São Gabriel,
São Gabriel, RS, Brazil; 30◦20′S, 54◦15′W).  Cattle were allowed to
graze freely on natural pastures, characterized by annual grass
species, and supplemented with mineral salt, receiving water ad
libitum. All animals were treated with levamisole (600 mg/100 kg
body weight) three times (days 22, 43 and 64) to avoid endoparasite
infestations along the vaccine trial, and managed under identical
conditions in the same paddock during the whole trial. Cattle were
managed in accordance with local institutional guidelines and all
procedures were in accordance with international guidelines [36].
2.3. Immunization protocols
Vaccinated and control groups were formed by 18 and 20 ani-
mals, respectively. Antigens were administered subcutaneously.
Each dose consisted of a mixture of recombinant proteins rBYC,
rGST-Hl and rVTDCE (200 g each, 0.5 mL)  mixed with 0.5 mL  of
adjuvant (Montanide 888 and Marcol 52), emulsiﬁed according to
the vortex method [37]. The control group received an emulsion
of PBS (0.5 mL)  plus adjuvant (0.5 mL). Both groups received three
booster injections at 21-day intervals (days 22, 43, and 64).
2.4.  Cattle sera collections and body weight
Blood samples (10 mL)  were collected via caudal vein from pre-
immunized and post-immunized cattle (days 1, 78 and 127), and
used for sera recovery. Blood samples were centrifuged at 5000 × g
for 10 min  and sera were stored at −20 ◦C. At days 1 and 127, all
bovines were weighted.
2.5.  SDS-PAGE and Western blot
SDS-PAGE and Western blot analysis were performed as
previously described [31]. Puriﬁed recombinant proteins (1 g pro-
tein/lane) were applied to SDS-PAGE (14% gel). For Western Blot,
the nitrocellulose membranes were incubated with cattle sera
(diluted 1:100) collected on days 1 and 78.
2.6. Antigen-speciﬁc IgG detection in sera by dot-blot
Levels of antigen-speciﬁc antibodies in the serum samples were
assessed by dot-blot. Nitrocellulose membrane circles of 0.5 cm of
diameter were coated with 1 g of each antigen in PBS. The mem-
branes were dried and incubated for 1 h at 37 ◦C with blotto [38],
followed by a second incubation with cattle sera diluted in blotto
(1:100) for 16 h at 37 ◦C. Washing times with blotto for 10 min
ensued, and the peroxidase conjugated antibody diluted in blotto
(1:5000) was  added and incubated for 1 h at 37 ◦C. After three
washes with PBS for 10 min, the membranes were incubated with
2.5 mg  3,3′-diaminobenzidine tetrahydrochloride, 10 L H2O2, and
150 L CoCl2 in 5 mL  of PBS. The recognition levels were quantiﬁed
by gel scanning, and were analyzed using the software Image J [39].
2.7. Tick analysis
Along  the vaccination trial, bovines were continuously exposed
to tick infestation (since the beginning of the immunization pro-
cess) because they were under natural conditions in a tick-infested
pasture. Attached adult female ticks (sized between 4.5 mm and
8.0 mm)  were counted on the left side of vaccinated and con-
trol groups, to follow the tick infestation rate [40]. Animals were
6914 L.F. Parizi et al. / Vaccine 30 (2012) 6912– 6917
Fig. 1. Purity and antigenicity of recombinant GST-Hl, VTDCE and BYC proteins,
analyzed  by 14% SDS-PAGE stained with Coomassie blue G-250 (A) and Western
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Fig. 2. Antigens-speciﬁc IgG levels from cattle sera analyzed by dot-blot. The levels
of recognition of pre-immunized (day 1) and post-immunized (days 78 and 127) cat-lot (B). Western blot was probed with the pre-immunized and post-immunized
era  from one bovine belonging to vaccinated group. Molecular mass standards are
xpressed as kDa.
mmobilized and ticks were counted by the same investigator. All
xaminations were carried out at the same period of the day (morn-
ng/afternoon). Tick count was a blind-procedure: the investigator
id not know which bovines belonged to control or vaccinated
roups.
.8. Statistical analysis
Statistical  signiﬁcance differences among the experimental
roups concerning level of antigen-speciﬁc antibodies, tick count
nd cattle body weight gain was analyzed by Student’s t test. Data
ere expressed as mean ± S.E.M. of each group. A p value of less
han 0.05 was considered signiﬁcant. Statistical analysis was per-
ormed using GraphPad Prism 3.0 (GraphPad Software Inc., San
iego, USA) software.
.  Results
.1. Production of recombinant proteins
The recombinant proteins BYC, GST-Hl and VTDCE were
xpressed in E. coli strains and puriﬁed by afﬁnity chromatogra-
hy. The purity of the three recombinant proteins was  analyzed by
 14% SDS-PAGE (Fig. 1A). All preparations showed a major pro-
ein band for rBYC, rGST-Hl, and rVTDCE in the gel, and these bands
atched the predicted molecular masses for respective proteins.
.2.  Development of humoral immune response in cattle
Dot  blot analysis revealed an increased antibody recognition
evel of vaccinated bovine sera (collected at day 78) to the three
ecombinant proteins, compared to the vaccinated bovine pre-
mmune sera (day 1) (Fig. 2). Compared to day 1, the level of
ecognition from vaccinated cattle sera on day 78 for rGST-Hl,
VTDCE and rBYC increased by more than 6, 10, and 2 times, respec-
ively. The level of recognition remained constant at the end of
he experiment (day 127) for rGST-Hl, reducing by half for rVT-
CE, and returning to pre-immunization level for rBYC. Also, theevel of recognition measured from vaccinated cattle sera was
pproximately 8, 4, and 2.5 times higher for rGST-Hl, rVTDCE, and
BYC respectively, than those recorded from animals injected with
lacebo on day 78.tle sera from vaccinated and control groups were analyzed for recombinant proteins
GST-Hl (A), VTDCE (B) and BYC (C). ***p < 0.001 (Student’s t-test).
Western blot revealed that sera from one representative
bovine of the vaccinated group recognize all recombinant proteins
(Fig. 1B). The proteins rBYC, rGST-Hl and rVTDCE were not recog-
nized by pre-immune serum of this animal.
3.3. Vaccination effect on tick infestation and body weight
The  reduction in the number of ticks attached to bovines con-
ferred by immunization with rBYC, rGST-Hl and rVTDCE is shown in
Fig. 3 and Table 1. In the ﬁrst three counts, tick number means from
both groups were similar. From the fourth count on (days 36–127),
means in the two groups were statistically different, except for
day 57. During this period, bovines vaccinated with recombinant
proteins showed statistical reductions that ranged from 35.3 to
61.6% (Table 1) in the number of semi-engorged ticks, as compared
with the control group. Interestingly, even before the immuniza-
tion period had ended it was already possible to detect a drop in
tick infestation (Fig. 3, day 36). Also, there was  an increase in cat-
tle body weight in both groups between days 1 and 127, although
the gain was  statistically higher in the vaccinated group (Fig. 4). In
L.F. Parizi et al. / Vaccine 30
Fig. 3. Kinetics of the average numbers of semi-engorged ticks in the vaccinated
and  control groups. Arrows indicate the days of immunization. *p < 0.05, **p < 0.01,
***p < 0.001 (Student’s t-test).
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(ig. 4. Body weight gain in cattle along the vaccination trial. Cattle body weight
ain  in vaccinated group and control groups is expressed as percentage of mean
ody  weight gain from day 1 to day 127. *p < 0.05 (Student’s t-test).
he vaccinated and control cattle groups, body weight gain was 39%
nd 25%, respectively..  Discussion
Tick vaccines derived from the gut antigen Bm86 have been
xtensively investigated in the quest for a suitable tick control
able 1
ffect  of cattle vaccination on the number of semi-engorged R. microplus females.
Day Tick count a
Control group Vaccinated group Difference (%) b
1 6.1 ± 2.4 5.3 ± 1.4 14.2
15  6.1 ± 1.3 4.5 ± 1.6 26.2
22  17.0 ± 2.4 13.2 ± 3.1 22.2
36  16.7 ± 2.3 9.3 ± 2.7 44.6*
43 18.2 ± 2.5 7.7 ± 1.3 57.9***
57 3.4 ± 0.6 2.7 ± 0.6 21.6
64  6.6 ± 1.2 2.6 ± 0.5 61.6**
78 8.8 ± 2.2 3.7 ± 0.6 58.3*
85 11.0  ± 1.7 4.8 ± 1.2 56.3**
99 25.9 ± 4.7 14.1 ± 2.6 45.8*
113 23.7 ± 2.8 12.9 ± 2.0 45.7**
127 46.4 ± 4.9 30.0 ± 4.4 35.3*
a Measured by counting the number of semi-engorged female ticks on the animals
average  values ± S.D.).
b Difference (%) = 100 × [1 − (vaccine/control)].
* p < 0.05 (Student’s t-test).
** p < 0.01 (Student’s t-test).
*** p < <0.001 (Student’s t-test). (2012) 6912– 6917 6915
method. This antigen was shown to be partially protective against R.
microplus ﬁeld infestations in Australia, Cuba, and in some regions
of Argentina, Brazil, Mexico and other countries [12,13,24,41,42].
These and other studies provide proof of concept for anti-arthropod
vaccines. Nevertheless, following the commercialization of Bm86-
based vaccines, a considerable body of results challenged the initial
optimism that Bm86 would be effective against all R. microplus
populations [24,43,44]. Consequently, there is a need to enhance
the efﬁcacy of the available tick vaccines as well as to develop
new ones against other tick species, especially of medical and
veterinary importance. Several antigens are currently under ﬁeld
investigation [14,45,46], though so far no single antigen has been
found to achieve the desired protection threshold against all tick
populations under ﬁeld conditions [14,45]. To increase the ﬁeld per-
formance of anti-tick vaccine candidates, it is theoretically possible
to design a multi-component vaccine, a concept that has already
been shown to work against other parasites [16,47,48]. Theoreti-
cally, vaccines composed of synergistic antigens could elicit more
effective responses against ticks [16]. However, limited studies
reporting comprehensive evaluation of the performance of tick
antigens cocktails against tick infestation have been published
[16–23].
The proteins selected as antigens in this study play crucial physi-
ological roles in ticks, such as vitellin mobilization (BYC and VTDCE)
[28,29,49] and detoxiﬁcation (GST) [50,51]. Indeed, previous stud-
ies demonstrated that these antigens, when administered in a mono
vaccine, induce partial protective immune responses [27,30,31]. In
these studies, the biological parameters evaluated to analyze tick
control were the number of fully engorged ticks, egg laying capac-
ity, and egg fertility, while the main parameter affected in ticks
fed on vaccinated cattle was the number of fully engorged ticks,
although the other parameters investigated were also affected,
improving overall protection. These studies also demonstrated the
immunogenicity of rGST-Hl, rBYC, and VTDCE and conﬁrmed that
speciﬁc IgG were elicited in vaccinated cattle for these proteins.
The  present work demonstrated that these three recombinant
proteins are immunogenic in cattle when administered simulta-
neously, although differences in immune response dynamics occur
between antigens. In agreement with previous studies [27,30,31],
we found that rGST-Hl elicited a more persistent humoral response
than rBYC and rVTDCE. Immunization with the three recombinant
proteins together induced a partial protective immune response in
the experimental animals, evidenced by a decrease in the number
of female ticks feeding on the vaccinated animals, in comparison
with the control group. The number of females feeding on the hosts
was statistically different between the two groups 14 days after the
second immunization, and remained lower in the vaccinated group
until the last day of the experiment (days 36–127). During days
43–85, vaccination conferred a statistically signiﬁcant protection
against tick infestation, ranging from 56.3 to 61.6%. However, the
protection decreased to 35.3% two  months after the last booster,
along a decrease in antibody levels to rBYC and rVTDCE, suggesting
the importance of these antibodies in protection rates obtained in
previous counts.
The  reduction in tick infestation following immunization with
the three proteins is directly correlated with cattle body weight
gain. Actually, body weight signals cattle ﬁtness, a major productive
parameter that is used as an indicator of vaccine effectiveness in
ﬁeld trials [1,41,42]. Under experimental conditions, body weight
gain was  signiﬁcantly higher in vaccinated animals than in the con-
trol group. This effect seems to be a result of reduction in cattle
damage by parasitism due to blood loss caused by the attaching
ticks, and consequently, an improving in the overall health of the
cattle.
In sum, the immune response generated by simultaneous vac-
cination with rGST-Hl, rBYC, and VTDCE affects tick physiology,
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ecreasing the number of females feeding in the host, resulting in
n improved body weight gain of cattle. When compared to rGST-
l, rBYC, or VTDCE single-antigenic vaccination in conﬁned cattle,
he multi-antigenic vaccine produced higher protection against
. microplus infestation. In spite of the differences between the
accination protocols, these results demonstrate the possibility of
eveloping a cattle multi-antigenic vaccine against R. microplus that
eems to be more effective than a single antigenic vaccine against
ick infestation under natural ﬁeld conditions. More work is nec-
ssary to evaluate the economic beneﬁts of a multi-antigen or a
ingle-antigen vaccine to control ticks. However, the use of such
accine, associated with existent and/or available control methods
ould result in a more efﬁcient control of R. microplus.
cknowledgments
The authors thank Omar Santana for animal handling, Rovaina
aureano Doyle and all staff of FEPAGRO São Gabriel for valuable
echnical support, Aoi Masuda for valuable comments, Naftaly W.
ithaka for his valuable English review of this article. This work was
upported by grants from Instituto Nacional de Ciência e Tecnologia
m Entomologia Molecular, CNPq, FEPAGRO, HHMI, FINEP, CAPES,
APERJ and FAPERGS.
ppendix  A. Supplementary data
Supplementary data associated with this article can be
ound, in the online version, at http://dx.doi.org/10.1016/j.vaccine.
012.08.078.
eferences
[1] Jonsson NN. The productivity effects of cattle tick (Boophilus microplus) infesta-
tion on cattle, with particular reference to Bos indicus cattle and their crosses.
Vet Parasitol 2006;137:1–10.
[2] de la Fuente J, Estrada-Pena A, Venzal JM,  Kocan KM,  Overview Sonenshine DE.
Ticks as vectors of pathogens that cause disease in humans and animals. Front
Biosci 2008;13:6938–46.
[3] Henrioud AN. Towards sustainable parasite control practices in livestock pro-
duction with emphasis in Latin America. Vet Parasitol 2011;180:2–11.
[4] Willadsen P. Anti-tick vaccines. Parasitology 2004;129:367–87.
[5] Seixas A, Oliveira P, Termignoni C, Logullo C, Masuda A, da Silva Vaz Jr I. Rhipi-
cephalus (Boophilus) microplus embryo proteins as target for tick vaccine. Vet
Immunol Immunopathol 2012;148:149–56.
[6] Akhtar M, Muhammad F, Lodhi LA, Hussain I, Anwar MI.  Immunity against
ticks––a review. Pak Vet J 2011;31:9–16.
[7] Willadsen P, Mckenna RV, Riding GA. Isolation from the cattle tick, B. microplus,
of antigenic material capable of eliciting a protective immunological response
in the bovine host. Int J Parasitol 1988;18:183–9.
[8]  Andreotti R, Pedroso MS,  Caetano AR, Martins NF. Comparison of predicted
binders in Rhipicephalus (Boophilus) microplus intestine protein variants Bm86
Campo Grande strain, Bm86 and Bm95. Rev Bras Parasitol Vet 2008;17:
93–8.
[9]  Ben Said M, Galai Y, Canales M,  Nijhof AM,  Mhadhbi M,  Jedidi M,  et al. Hd86, the
Bm86 tick protein ortholog in Hyalomma scupense (syn. H. detritum): expres-
sion in Pichia pastoris and analysis of nucleotides and amino acids sequences
variations prior to vaccination trials. Vet Parasitol 2012;183:215–23.
10] Freeman JM,  Davey RB, Kappmeyer LS, Kammlah DM,  Olafson PU. Bm86 midgut
protein sequence variation in South Texas cattle fever ticks. Parasite Vectors
2010;3:101.
11]  Penichet M,  Rodriguez M,  Castellano O, Mandado S, Rojas Y, Rubiera R, et al.
Detection of Bm86 antigen in different strains of Boophilus microplus and
effectiveness of immunization with recombinant Bm86. Parasite Immunol
1994;16:493–500.
12]  Rodriguez M,  Massard CL, da Fonseca AH, Ramos NF, Machado H, Labarta V,
et al. Effect of vaccination with a recombinant Bm86 antigen preparation on
natural infestations of Boophilus microplus in grazing dairy and beef pure and
cross-bred cattle in Brazil. Vaccine 1995;13:1804–8.
13]  Rodríguez M,  Penichet ML,  Mouris AE, Labarta V, Luaces LL, Rubiera R,
et al. Control of Boophilus microplus populations in grazing cattle vacci-
nated with a recombinant Bm86 antigen preparation. Vet Parasitol 1995;57:
339–49.
14] Parizi LF, Githaka NW,  Logullo C, Konnai S, Masuda A, Ohashi K, da Silva
Vaz Jr. Universal vaccine against ticks: cross-immunity insights. Vet J;
http://dx.doi.org/10.1016/j.tvjl.2012.05.023, in press.
[ (2012) 6912– 6917
15]  Kumar B, Azhahianambi P, Ray DD, Chaudhuri P, de la Fuente J, Kumar R,
et al. Comparative efﬁcacy of rHaa86 and rBm86 against Hyalomma ana-
tolicum anatolicum and Rhipicephalus (Boophilus) microplus. Parasite Immunol
2012;34:297–301.
16]  Willadsen P. Antigen cocktails: valid hypothesis or unsubstantiated hope. Para-
sitol Today 2008;24:164–7.
17] Willadsen P, Smith D, Cobon G, McKenna RV. Comparative vaccination of
cattle against Boophilus microplus with recombinant antigen Bm86 alone
or in combination with recombinant Bm91. Parasite Immunol 1996;18:
241–6.
18] McKenna RV, Riding GA, Jarmey JM,  Pearson RD, Willadsen P. Vaccination of cat-
tle against the Boophilus microplus using a mucin-like membrane glycoprotein.
Parasite Immunol 1998;20:325–36.
19] Andreotti R, Gomes A, Malavazi-Piza KC, Sasaki SD, Sampaio CAM, Tanaka AS.
BmTI antigens induce a bovine protective immune response against Boophilus
microplus tick. Int Immunopharmacol 2002;2:557–63.
20]  Almazan C, Kocan KM,  Blouin EE, de la Fuente J. Vaccination with recombi-
nant tick antigens for the control of Ixodes scapularis adult infestations. Vaccine
2005;23:5294–8.
21] Imamura S, Namangala B, Tajima T, Tembo ME,  Yasuda J, Ohashi K, et al.
Two serine protease inhibitors (serpins) that induce a bovine protective
immune response against Rhipicephalus appendiculatus ticks. Vaccine 2006;24:
2230–7.
22]  Imamura S, Konnai S, Junior IDV, Yamada S, Nakajima C, Ito Y, et al. Effects
of anti-tick cocktail vaccine against Rhipicephalus appendiculatus. Jpn J Vet Res
2008;56:85–98.
23]  Almazan C, Moreno-Cantu O, Moreno-Cid JA, Galindo RC, Canales M,  Villar M,
et al. Control of tick infestations in cattle vaccinated with bacterial membranes
containing surface-exposed tick protective antigens. Vaccine 2012;30:265–72.
24]  de la Fuente J, Rodriguez M,  Montero C, Redondo M,  Garcia-Garcia JC, Mendez L,
et  al. Vaccination against ticks (Boophilus spp.): the experience with the Bm86-
based vaccine Gavac (TM). Genet Anal 1999;15:143–8.
25]  Vargas M, Montero C, Sánchez D, Pérez D, Valdés M,  Alfonso A, et al. Two ini-
tial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus
(Boophilus) microplus induce similar reproductive suppression to three initial
vaccinations under production conditions. BMC  Vet Res 2010;6:43.
26] da Silva Vaz Jr I, Logullo I, Sorgine M, Velloso FF, Rosa de Lima MF,
Gonzales JC, et al. Immunization of bovines with an aspartic proteinase pre-
cursor isolated from Boophilus microplus eggs. Vet Immunol Immunopathol
1998;66(December):331–41.
27] Leal AT, Seixas A, Pohl PC, Ferreira CAS, Logullo C, Oliveira PL, et al. Vaccina-
tion of bovines with recombinant Boophilus yolk pro-cathepsin. Vet Immunol
Immunopathol 2006;114:341–5.
28] Seixas A, Dos Santos PC, Velloso FF, da Silva Vaz Jr I, Masuda A, Horn F, et al.
A Boophilus microplus vitellin-degrading cysteine endopeptidase. Parasitology
2003;126:155–63.
29]  Seixas A, Estrela AB, Ceolato JC, Pontes EG, Lara F, Gondim KC, et al. Localization
and function of Rhipicephalus (Boophilus) microplus vitellin-degrading cysteine
endopeptidase. Parasitology 2010;137:1819–31.
30]  Seixas A, Leal AT, Nascimento-Silva MC, Masuda A, Termignoni C, da Silva Vaz Jr
I.  Vaccine potential of a tick vitellin-degrading enzyme (VTDCE). Vet Immunol
Immunopathol 2008;124:332–40.
31] Parizi LF, Utiumi KU, Imamura S, Onuma M,  Ohashi K, Masuda A, et al. Cross
immunity with Haemaphysalis longicornis glutathione S-transferase reduces
an experimental Rhipicephalus (Boophilus) microplus infestation. Exp Parasitol
2011;127:113–8.
32]  da Silva Vaz Jr I, Imamura S, Ohashi K, Onuma M.  Cloning, expression and partial
characterization of a Haemaphysalis longicornis and a Rhipicephalus appendicu-
latus glutathione S-transferase. Insect Mol  Biol 2004;13:329–35.
33]  Leal AT, Pohl PC, Ferreira CAS, Nascimento-Silva MC,  Sorgine MH,  Logullo
C, et al. Puriﬁcation and antigenicity of two recombinant forms of Boophilus
microplus yolk pro-cathepsin expressed in inclusion bodies. Protein Exp Purif
2006;45:107–14.
34] Oldiges DP, Parizi LF, Zimmer KR, Lorenzini DM,  Seixas A, Masuda A, et al. A
Rhipicephalus (Boophilus) microplus cathepsin with dual activity: peptidase and
antimicrobial. Int J Parasitol 2012;42:635–45.
35] Bradford MM.  Rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing principle of protein–dye binding. Anal Biochem
1976;72:248–54.
36]  Federation of Animal Science Societies (FASS)., 1999. Guide for the care and use
of agricultural animals in agricultural research and teaching. 2nd ed. Savoy:
FASS; 1999.
37] Dallas BF, Lieping C. A simple and rapid vortex method for prepar-
ing antigen/adjuvant emulsions for immunization. J Immunol Methods
2003;276:239–42.
38]  Johnson DA, Gautsch JW,  Sportsman JR, Elder JH.  Improved technique utiliz-
ing nonfat dry milk for analysis of proteins and nucleic acids transferred to
nitrocellulose. Gene Anal Tech 1984;1:3–8.
39]  Abramoff MD,  Magalhaes PJ, Ram SJ. Image Processing with ImageJ. Biophoton
Int 2004;11:36–42.
40] Wharton RH, Utech KBW. The relation between engorgement and dropping of
Boophilus microplus (Canestkini) (Ixodidae) to the assessment of tick numbers
on cattle. J Aust Entamol Soc 1970;9:171–82.
41] de la Fuente J, Rodríguez M,  Redondo M,  Montero C, García-García JC, Méndez
L, et al. Field studies and cost-effectiveness of vaccination with Gavac against
the cattle tick Boophilus microplus. Vaccine 1998;16:366–73.
cine 30
[
[
[
[
[
[
[
[
[L.F. Parizi et al. / Vac
42] Jonsson NN, Matschoss AL, Pepper P, Green PE, Albrecht MS,  Hunterford J, et al.
Evaluation of TickGARD(PLUS), a novel vaccine against Boophilus microplus, in
lactating Holstein–Friesian cows. Vet Parasitol 2000;88:275–85.
43]  García-García JC, Gonzalez IL, Gonzalez DM,  Valdes M,  Mendez L, Lamberti J,
et al. Sequence variations in the Boophilus microplus Bm86 locus and implica-
tions for immunoprotection in cattle vaccinated with this antigen. Exp Appl
Acarol 1999;23:883–95.
44] Garcia-Garcia JC, Montero C, Redondo M,  Vargas M,  Canales M,  Boue O, et al.
Control of ticks resistant to immunization with Bm86 in cattle vaccinated
with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus
microplus. Vaccine 2000;18:2275–87.45] de la Fuente J, Kocan KM.  Strategies for development of vaccines for control of
ixodid tick species. Parasite Immunol 2006;28:275–83.
46] Parizi LF, Pohl PC, Masuda A, da Silva Vaz Jr I. New approaches toward
anti-Rhipicephalus (Boophilus) microplus tick vaccine. Rev Bras Parasitol Vet
2009;18:1–7.
[ (2012) 6912– 6917 6917
47] Lightowlers MW,  Rolfe R, Gauci CG. Taenia saginata: vaccination against
cysticercosis in cattle with recombinant oncosphere antigens. Exp Parasitol
1996;84:330–8.
48]  Doolan DL, Hoffman SL. DNA-based vaccines against malaria: status and
promise of the multi-stage malaria dna vaccine operation. Int J Parasitol
2001;31:753–62.
49]  Logullo C, Vaz IS, Sorgine MH, Paiva-Silva GO, Faria FS, Zingali RB, et al. Isola-
tion of an aspartic proteinase precursor from the egg of a hard tick, Boophilus
microplus. Parasitology 1998;116:525–32.
50] Wei SH, Clark AG, Syvanen M.  Identiﬁcation and cloning of a key insecticide-
metabolizing glutathione S-transferase (MdGST-6A) from a hyperinsecticide-
resistant strain of the houseﬂy Musca domestica. Insect Biochem Mol Biol
2001;31:1145–53.
51] da Silva Vaz Jr I, Lermen TT, Michelon A, Ferreira CAS, de Freitas DRJ, Termignoni
C, et al. Effect of acaricides on the activity of a Boophilus microplus glutathione
S-transferase. Vet Parasitol 2004;119:237–45.
